Cutaneous CD30 (Ki‐1)‐Positive Anaplastic Large Cell Lymphoma Preceded by Hodgkin's Disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1346-8138|27|3|170-173

ISSN： 0385-2407

Source： THE JOURNAL OF DERMATOLOGY, Vol.27, Iss.3, 2000-03, pp. : 170-173

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Case of Cutaneous Ki‐1 Positive Anaplastic Large Cell Lymphoma in a Hemodialysed Patient

By  

THE JOURNAL OF DERMATOLOGY, Vol. 25, Iss. 3, 1998-03 ,pp. : 190-194

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cutaneous infiltration of anaplastic variant of CD30‐positive diffuse large B‐cell lymphoma

By  

AUSTRALASIAN JOURNAL OF DERMATOLOGY, Vol. 59, Iss. 1, 2018-02 ,pp. : 65-67

John Wiley & Sons Inc

Access to resources Recommend Favorite

Primary Cutaneous Ki‐1+ Anaplastic Large Cell Lymphoma: A Morphologic, Immunohistochemical and Genetic Study of an Indolent Case

By  

THE JOURNAL OF DERMATOLOGY, Vol. 22, Iss. 6, 1995-06 ,pp. : 441-449

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lymphomatoid Papulosis Followed by Ki‐1 Positive Anaplastic Large Cell Lymphoma: Proliferation of a Common T‐Cell Clone

By  

THE JOURNAL OF DERMATOLOGY, Vol. 22, Iss. 10, 1995-10 ,pp. : 743-746

John Wiley & Sons Inc

Access to resources Recommend Favorite

Brentuximab vedotin is an effective therapy for CD30+ mycosis fungoides and cutaneous anaplastic large‐cell lymphoma: what is the cost?

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 177, Iss. 6, 2017-12 ,pp. : 1474-1475

John Wiley & Sons Inc

Access to resources Recommend Favorite